Role and new insights of microfibrillar-associated protein 4 in fibrotic diseases

APMIS. 2024 Feb;132(2):55-67. doi: 10.1111/apm.13358. Epub 2023 Nov 13.

Abstract

Fibrosis is one of the most worrisome complications of chronic inflammatory diseases, leading to tissue damage, organ failure, and ultimately, death. The most notable pathological characteristic of fibrosis is the excessive accumulation of extracellular matrix (ECM) components such as collagen and fibronectin adjacent to foci of inflammation or damage. The human microfibrillar-associated protein 4 (MFAP4), an important member of the superfamily of fibrinogen-related proteins, is considered to have an extremely important role in ECM transformation of fibrogenesis. This review summarizes the structure, characteristics, and physiological functions of MFAP4 and the importance of MFAP4 in various fibrotic diseases. Meanwhile, we elaborated the underlying actions and mechanisms of MFAP4 in the development of fibrosis, suggesting that a better understand of MFAP4 broadens novel perspective for early screening, diagnosis, prognostic risk assessment, and treatment of fibrotic diseases.

Keywords: ECM protein; Microfibrillar-associated protein 4; extracellular matrix; fibrosis; fibrotic diseases.

Publication types

  • Review

MeSH terms

  • Carrier Proteins*
  • Extracellular Matrix Proteins
  • Fibrosis
  • Glycoproteins*
  • Humans
  • Prognosis

Substances

  • MFAP4 protein, human
  • Carrier Proteins
  • Glycoproteins
  • Extracellular Matrix Proteins